Stimulation of Cell Proliferation and Estrogenic Response by Adrenal C19-Δ5-Steroids in the ZR-75-1 Human Breast Cancer Cell Line

Cancer Research

Volumn 46, Issue 10, 1986, Pages 4933-4937

  Poulin, Richard ^a   Labrie, Fernand ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIOL; ESTRADIOL; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE RECEPTOR; PROMEGESTONE; RADIOISOTOPE; RALOXIFENE;

ANDROST 5 ENE 3BETA,17BETA DIOL; BREAST; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; DRUG EFFICACY; ESTRADIOL H 3; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROMEGESTONE H 3; STRUCTURE ACTIVITY RELATION; TUMOR CELL;

ANDROST-5-ENE-3 BETA,17 BETA-DIOL; ANDROSTENEDIOLS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HUMAN; PRASTERONE; RECEPTORS, PROGESTERONE; SUPPORT, NON-U.S. GOV'T;

EID: 0022536513     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Poulin, R., and Labrie, F. Stimulation of cell growth by Ci9 steroids of adrenal origin in A human breast cancer cell line (abstract). Clin. Invest. Med., 8: A162, 1985.
2. Lippman, M. E. Antiestrogen therapy of breast cancer. Semin. Oncol., 10 (Suppl. 4): 11-19, 1983.
3. Lippman, M. E. Growth regulation of human breast cancer. Clin. Res., 34: 374-382, 1985.
4. Sledge, G. W., Jr., and McGuire, W. L. Steroid hormone receptors in human breast cancer. Adv. Cancer Res., 38:61-75,1984.
5. Wittliff, J. L. Steroid-hormone receptors in breast cancer. Cancer (Phila.), 53:630-643, 1984.
6. Adams, J. B. Control of secretion and the function of Ci9-A5-steroids of the human adrenal gland. Mol. Cell. Endocrinol., 41: 1-17,1985.
7. Rochefort, H., and Garcia, M. The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol. Ther., 23:193-216,1984.
8. Seymour-Munn, K., and Adams, J. B. Estrogenic effects of 5-androstene-30,170-diol at physiological concentrations and its possible implication in the etiology of breast cancer. Endocrinology, 112:486-491,1983.
9. Adams, J. B., Garcia, M., and Rochefort, H. Estrogenic effects of physiological concentrations of 5-androstene-30,170-diol and its metabolism in MDF- 7 human breast cancer cells. Cancer Res., 41:4720-4726,1981.
10. Kreitmann, B., and Bayard, F. Androgen interaction with the oestrogen receptor in human tissues. J. Steroid Biochem., 11:1589-1595,1979.
11. Poortman, J., Prenen, J. A. C., Schwarz, F., and Thijssen, J. H. H. Interaction of A5-androstene-3/S, 170-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J. Clin. Endocrinol. Metab., 40:373-379, 1975.
12. Engel, L. W., Young, N. A., Tralka, T. S., Lippman, M. E., O’Brien, S. J., and Joyce, M. J. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res., 38: 3352-3364, 1978.
13. Darbre, P., Yates, J., Curtis, S., and King, R. J. B. Effect of estradiol on human breast cancer cells in culture. Cancer Res., 43: 349-354,1983.
14. Allegra, J. C., and Lippman, M. E. The effects of 170-estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium. Eur. J. Cancer, 16:1007-1015,1980.
15. Darbre, P. D., Curtis, S., and King, R. J. B. Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. Cancer Res., 44: 2790-2793, 1984.
16. Calvo, F., Brower, M., and Carney, D. N. Continuous culture and soft agarose cloning of multiple human breast carcinoma cell lines in serum-free medium. Cancer Res., 44:4553-4559, 1984.
17. Taylor, C. M., Blanchard, B., and Zava, D. T. A simple method to determine whole cell uptake of radiolabeled oestrogens and progesterone and their subcellular localization in breast cancer cell lines in monolayer cultures. J. Steroid Biochem., 20:1083-1088,1984.
18. Lippman, M. E. Definition of hormones and growth factors required for optimal proliferation and expression of phenotypic responses in human breast cancer cells. In: D. W. Barnes, D. A. Sirbasku, and G. H. Sato (eds.), Cell Culture Methods for Molecular and Cell Biology, Vol. 2, pp. 183-200. New York: Alan R. Liss/Wiley, 1984.
19. Scatchard, G. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci., 51:660-672, 1959.
20. Maroulis, G. B., and Abraham, G. E. Ovarian and adrenal contribution to peripheral steroid levels in post-menopausal women. Obstet. Gynecol., 48: 150-154,1976.
21. Rosenfield, R. L., and Otto, P. Androstenediol levels in human peripheral plasma. J. Clin. Endocrinol. Metab., 35:818-822,1972.
22. Clemens, J. A., Bennett, D. R., Black, L. J., and Jones, C. D. Effects of A new antiestrogen, keoxifene (LY156758), on growth of carcinogen–induced mammary tumors and on LH and prolactin levels. Life Sci., 32:2869-2875, 1983.
23. Simard, J., and Labrie, F. Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs. Mol. Cell. Endocrinol., 39:141-144,1985.
24. Cheng, Y., and Prusoff, W. H. Relationship between the inhibition constant (A'i) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol., 22:3099-3108,1973.
25. Horwitz, K. B., and McGuire, W. L. Estrogen control of progesterone receptors in human breast cancer. J. Biol. Chem., 253:2223-2228,1978.
26. Abul-Hajj, Y. J. Metabolism of dehydroepiandrosterone by hormone-dependent and hormone-independent human breast carcinoma. Steroids, 26: 488-500,1975.
27. McLndoe, J. H. Estradiol formation from testosterone by continuously cultured human breast cancer cells. J. Clin. Endocrinol. Metab., 49: 272-277, 1979.
28. Perel, E., Wilkins, D., and Killinger, D. W. The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue. J. Steroid Biochem., 13:89-94, 1980.
29. Smith, M., Rudd, B„ Shirley, A., Rayner, P., Williams, J., Duignan, N., and Bertrand, P. A radioimmunoassay for the estimation of serum dehydroepiandrosterone sulphate in normal and pathological sera. Clin. Chim. Acta, 65: 5-13,1975.
30. Bird, C. E., Morrow, L., Fukumoto, Y., Marcellus, S., and Clark, A. F. A5- Androstenediol: kinetics of metabolism and binding to plasma proteins in normal men and women. J. Clin. Endocrinol. Metab., 43:1317-1322,1976.
31. Bird, C. E., Murphy, J., Boroomand, K., Finnis, W., Dressel, D., and Clark, A. F. Dehydroepiandrosterone: Kinetics of metabolism in normal men and women. J. Clin. Endocrinol. Metab., 47:818-822,1978.
32. Adams, J. B., Archibald, L., and Seymour-Munn, K. Dehydroepiandrosterone and androst-5-ene-30,17/9-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor. Cancer Res., 40:3815-3820,1980.
33. Bonney, R. C., Scanlon, M. J., Reed, M. J., Jones, D. L., Beranek, P. A., and James, V. H. T. Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism. J. Steroid Biochem., 20:501-504, 1984.
34. Van Landeghem, A. A. J., Poortman, J., Nabuurs, M., and Thijssen, J. H. H. Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue. Cancer Res., 45: 2907-2912, 1985.
35. Adams, J. B., and Wang, M. S. F. Paraendocrine behaviour of human breast carcinoma. In vitro transformation of steroids to physiologically active hormones. J. Endocrinol., 41:41-52,1968.
36. Li, K., Foo, T., and Adams, J. B. Products of dehydroepiandrosterone metabolism by human mammary tumors and their influence on estradiol receptor binding. Steroids, 31:113-127, 1978.
37. Allegra, J. C. Rational approaches to the hormonal treatment of breast cancer. Semin. Oncol., 10 (Suppl. 4); 25-28,1983.
38. Siiteri, P. K., and McDonald, D. C. The role of extraglandular estrogens in human endocrinology. In: S. R. Geiger, E. B. Astwood, and R. O. Greep (eds.), Handbook of Physiology, Sect. 7, pp. 615-619. New York: The American Physiology Society, 1973.
39. Carlstrom, K. Influence of intratumoral estradiol biosynthesis on estrogen receptors. Recent Results Cancer Res., 91:145-149,1984.
40. Garcia, M., and Rochefort, H. Evidence and characterization of the binding of two 3H-labeled androgens to the estrogen receptor. Endocrinology, 104: 1797-1804,1979.